0 participants
Decitabine and Arsenic Trioxide for Myelodysplastic Syndrome(MDS)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2023-08-16
- Start Date:
- 2018-03-20
- Completion:
- 2018-03-31
Conditions
- Myelodysplastic Syndromes
- P53 Mutation
Interventions
- DRUG
No Results Yet